AlphaMadera's AlphaVal page classifies Conagra Brands, Inc. as a Stable Earnings Power business and values it using P/Adj-EPS × Normalized Multiple, then compares the result to the current market price to flag CAG as undervalued, fairly valued, or overvalued.

What is Conagra Brands, Inc.'s fair value?

Fair value for CAG comes from a P/Adj-EPS × Normalized Multiple model -- the approach AlphaVal selected for this company's Stable Earnings Power classification. The live AlphaVal page shows bear, base, and bull scenarios alongside the key assumption behind each.

How does AlphaMadera value CAG?

AlphaVal routes each company to one of ten valuation archetypes based on its business model. CAG was classified as Stable Earnings Power and is valued using P/Adj-EPS × Normalized Multiple, built from CAG's most recent reported fundamentals.

CAG - Conagra Brands, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS | PRICE TARGET: $13.89 DETAILS

AlphaVal

Deterministic, archetype-aware fair value

Stable Earnings Power 40% confidence

Primary model: P/Adj-EPS × Normalized Multiple

Valuation Signal Undervalued Strong

Trading 48.3% below fair value

Current Price $14.26

Bear Case $22.71 59.3% upside ($22.71 - $14.26) / $14.26 = 59.3% $1.62 × 14x P/E

Fair Value $27.57 93.4% upside ($27.57 - $14.26) / $14.26 = 93.4% $1.62 × 17x P/E

Bull Case $32.44 127.6% upside ($32.44 - $14.26) / $14.26 = 127.6% $1.62 × 20x P/E

Adjust Assumptions

P/E Multiple

17.0x

Adjusted EPS

1.62$

Key Value Driver

Normalized P/E multiple (17x base case)

Terminal Value % of EV

Implied Market Multiple 8.8x

Market is pricing in (growth)

Plain-Language Summary

Applying a 17x P/E to adjusted EPS of $1.62, the base-case value is $27.57 per share.

Analyst Consensus (External Reference)

Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.

Average Target (25 analysts) $13.89

Analyst Range $12.00 – $16.00

Divergence from AlphaVal 98%

Warnings

ℹ Wall Street's average price target is $13.89 (from 25 analysts). Our estimate is 98% above the consensus -- consider that gap carefully.

Key Risks

Growth DCF inappropriate — terminal value assumptions dominate
EV/EBITDA misleading for regulated businesses where capex is mandated
Regulatory risk is a fat tail not visible in normal multiples